Abstract
It was previously reported that the up-regulation of ERp29 mRNA depends on the levels of thyroid stimulating hormone (TSH) in the thyrocytes of FRTL-5 cells. In order to investigate the putative new function of ERp29 as an endoplasmic molecular (ER) chaperone, an ERp29-overexpressing FRTL-5 cell line was established. This cell line had approximately three times the levels of ERp29 protein and an enhanced level of thyroglobulin (Tg) secretion. The results showed both enhanced ERp29 expression and an interaction with the other ER chaperones such as GRP94, BiP, ERp72 and calnexin. In addition, ERp29 enhanced the expression of PKR-like ER kinase (PERK), which is a transmembrane protein located in the ER membrane. These findings suggest that ERp29 assists in protein folding as well as in the secretion of the secretory/plasma membrane proteins under close co-operation with other ER chaperones and the ER stress signaler, PERK.
Similar content being viewed by others
References
L Ellgaard A Helenius (2003) Nat. Rev. Mol. Cell Biol. 3 181–191
F Callea M Brisigotti G Fabbretti F Bonino VJ Desmet (1992) Liver 6 357–362
PS Kim P Arvan (1998) Endocr. Rev. 19 173–202 Occurrence Handle1:CAS:528:DyaK1cXis1Wqs74%3D Occurrence Handle9570036
PS Kim SA Hossain YN Park I Lee SE Yoo P Arvan (1998) Proc. Natl. Acad. Sci. USA 95 9909–99013 Occurrence Handle1:CAS:528:DyaK1cXlsFSru7o%3D Occurrence Handle9707574
PS Kim M Ding S Menon CJ Jung JM Cheng T Miyamoto B Li S Furudate T Agui (2000) Mol. Endocrinol. 14 1944–1953 Occurrence Handle1:CAS:528:DC%2BD3cXos1Sqs7g%3D Occurrence Handle11117525
D Ferrari P Pinton G Szabadkai M Chami M Campanella T Pozzan R Rizzuto (2002) Cell Calcium 32 413–420 Occurrence Handle1:CAS:528:DC%2BD3sXhtFKnuro%3D Occurrence Handle12543100
HP Harding M Calfon F Urano I Novoa D Ron (2002) Annu. Rev. Cell Dev. Biol. 18 575–599 Occurrence Handle1:CAS:528:DC%2BD38XptVOqs70%3D Occurrence Handle12142265
H Kim S Park JM Suh HK Chung M Shong OY Kwon (2001) Cell Physiol. Biochem. 11 247–252 Occurrence Handle1:CAS:528:DC%2BD3MXnvVClurc%3D Occurrence Handle11684813
OY Kwon S Park W Lee KH You H Kim M Shong (2000) FEBS Lett 475 27–30 Occurrence Handle1:CAS:528:DC%2BD3cXktVSnt7k%3D Occurrence Handle10854851
S Park HM Hwang YH Lee KH You KS Shin OY Kwon (2003) Korean J. Biol. Sci. 7 265–269 Occurrence Handle1:CAS:528:DC%2BD3sXos1CktLk%3D
J Demmer C Zhou MJ Hubbard (1997) FEBS Lett 402 145–150 Occurrence Handle1:CAS:528:DyaK2sXptlShtQ%3D%3D Occurrence Handle9037184
S Mkrtchian C Fang U Hellman M Ingelman-Sundberg (1998) Eur. J. Biochem. 251 304–313 Occurrence Handle1:CAS:528:DyaK1cXnvV2rtQ%3D%3D Occurrence Handle9492298
MJ Hubbard NJ McHugh DL Carne (2000) Eur. J. Biochem. 267 1945–1957 Occurrence Handle1:CAS:528:DC%2BD3cXisVCisLg%3D Occurrence Handle10727933
SD Shnyder MJ Hubbard (2002) J Histochem. Cytochem. 50 557–566 Occurrence Handle1:CAS:528:DC%2BD38Xis1WntLw%3D Occurrence Handle11897809
S Mkrtchian M Baryshev O Matvijenko A Sharipo T Sandalova G Schneider M Ingelman-Sundberg S Mkrtchiana (1998) FEBS Lett 431 322–326 Occurrence Handle1:CAS:528:DyaK1cXltFWrsLg%3D Occurrence Handle9714535
E Liepinsh M Baryshev A Sharipo M Ingelman-Sundberg G Otting S Mkrtchian (2001) Structure 9 457–471 Occurrence Handle1:CAS:528:DC%2BD3MXkvVekur8%3D Occurrence Handle11435111
E Sargsyan M Baryshev M Backlund A Sharipo S Mkrtchian (2002) Gene 285 127–139 Occurrence Handle1:CAS:528:DC%2BD38XitlWmt7c%3D Occurrence Handle12039039
E Sargsyan M Baryshev L Szekely A Sharipo S Mkrtchian (2002) J. Biol. Chem. 277 17009–17015 Occurrence Handle1:CAS:528:DC%2BD38XjslWhu74%3D Occurrence Handle11884402
K Emoto O Kuge M Nishijima M Umeda (1999) Proc. Natl. Acad. Sci. USA 96 12400–12405 Occurrence Handle1:CAS:528:DyaK1MXnt1yrtbs%3D Occurrence Handle10535934
T Kimura A Keymeulen ParticleVan J Golstein A Fusco JE Dumont PP Roger (2001) Endocr Rev. 22 631–656 Occurrence Handle1:CAS:528:DC%2BD3MXotVWmu7g%3D Occurrence Handle11588145
PS Kim D Bole P Arvan (1992) J. Cell Biol. 118 541–549 Occurrence Handle1:CAS:528:DyaK38XkvVOgtLo%3D Occurrence Handle1353499
G Medeiros-Neto PS Kim SE Yoo J Vono HM Targovnik R Camargo SA Hossain P Arvan (1996) J. Clin. Invest. 98 2838–2844 Occurrence Handle1:CAS:528:DyaK2sXivVSk Occurrence Handle8981932
PS Kim OY Kwon P Arvan (1996) J. Cell Biol. 133 517–527 Occurrence Handle1:CAS:528:DyaK28XivVKnt7o%3D Occurrence Handle8636228
AA Welihinda W Tirasophon RJ Kaufman (1999) Gene Expr. Patterns 7 293–300 Occurrence Handle1:CAS:528:DyaK1MXltVKmtL8%3D
R Chapman C Sidrauski P Walter (1998) Annu. Rev. Cell Dev. Biol. 14 459–485 Occurrence Handle1:CAS:528:DyaK1cXnvFyisr0%3D Occurrence Handle9891790
HP Harding Y Zhang D Ron (1999) Nature 397 271–274 Occurrence Handle1:CAS:528:DyaK1MXpvVGrtA%3D%3D Occurrence Handle9930704
RJ Kaufman (1999) Genes Dev 13 1211–1233 Occurrence Handle1:CAS:528:DyaK1MXjslGjtbg%3D Occurrence Handle10346810
H Yoshida T Matsui A Yamamoto T Okada K Mori (2001) Cell 107 881–891 Occurrence Handle1:CAS:528:DC%2BD38XjtlKlsg%3D%3D Occurrence Handle11779464
C Patil P Walter (2001) Curr. Opin. Cell Biol. 13 349–355 Occurrence Handle1:CAS:528:DC%2BD3MXktVaju7c%3D Occurrence Handle11343907
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, S., You, KH., Shong, M. et al. Overexpression of ERp29 in the thyrocytes of FRTL-5 cells. Mol Biol Rep 32, 7–13 (2005). https://doi.org/10.1007/s11033-004-3069-3
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11033-004-3069-3